AG
ODT

Advisor Group’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Advisor Group’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$2K Hold
53
– – ﹤0.01% 5054
2019
Q3 		$1K Buy
+53
New +$1.77K ﹤0.01% 5210
2018
Q4 		– Sell
-500
Closed -$10K – 5317
2018
Q3 		$10K Sell
500
-500
-50% -$10.2K ﹤0.01% 4301
2018
Q2 		$22K Hold
1,000
– – ﹤0.01% 3665
2018
Q1 		$21K Buy
+1,000
New +$23.6K ﹤0.01% 3660

Other funds holding ODT

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Advisor Group's ODT Position: Q4 2019 in Review

Advisor Group held its Odonate Therapeutics, Inc. Common Stock (ODT) position steady in Q4 2019 at 53 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #5054.

Advisor Group first reported a position in ODT in Q1 2018 and has held it in 5 quarters since. The position peaked at $22K in Q2 2018. 88 funds tracked by Wall St. Rank hold ODT as of Q4 2019.

  • Advisor Group held 53 shares of Odonate Therapeutics, Inc. Common Stock worth $2K as of Q4 2019.
  • Advisor Group left its Odonate Therapeutics, Inc. Common Stock share count unchanged in Q4 2019.
  • Odonate Therapeutics, Inc. Common Stock made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #5054 holding.
  • Advisor Group first reported a position in Odonate Therapeutics, Inc. Common Stock in Q1 2018 and has held it in 5 quarters since.
  • Advisor Group's Odonate Therapeutics, Inc. Common Stock position peaked at $22K in Q2 2018.
  • 88 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.